{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T01:39:57Z","timestamp":1783561197603,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R03 DA036802"],"award-info":[{"award-number":["R03 DA036802"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30 DA13429"],"award-info":[{"award-number":["P30 DA13429"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AT006899"],"award-info":[{"award-number":["AT006899"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ejphar.2016.03.061","type":"journal-article","created":{"date-parts":[[2016,4,3]],"date-time":"2016-04-03T06:41:51Z","timestamp":1459665711000},"page":"53-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test"],"prefix":"10.1016","volume":"781","author":[{"given":"Peng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Tunis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Parry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Tallarida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-Yuan.","family":"Liu-Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2016.03.061_bib1","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/jnr.22259","article-title":"Cocaine withdrawal-induced anxiety in females: impact of circulating estrogen and potential use of delta-opioid receptor agonists for treatment","volume":"88","author":"Ambrose-Lanci","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ejphar.2016.03.061_bib2","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1517\/13543784.6.10.1351","article-title":"Novel developments with selective, non-peptidic kappa-opioid receptor agonists","volume":"6","author":"Barber","year":"1997","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.ejphar.2016.03.061_bib3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00213-005-0167-4","article-title":"Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats","volume":"183","author":"Beardsley","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.061_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00213-002-1179-y","article-title":"Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats","volume":"164","author":"Broom","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.061_bib5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0893-133X(01)00413-4","article-title":"Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats","volume":"26","author":"Broom","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.061_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","article-title":"The dynorphin\/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors","volume":"1314","author":"Bruchas","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2016.03.061_bib7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/npp.2009.183","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats","volume":"35","author":"Carr","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.061_bib8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2004.08.028","article-title":"Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist","volume":"501","author":"Carroll","year":"2004","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.ejphar.2016.03.061_bib9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bbr.2014.10.029","article-title":"Delta opioid receptors expressed in forebrain GABAergic neurons are responsible for SNC80-induced seizures","volume":"278","author":"Chung","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2016.03.061_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pharmthera.2013.06.003","article-title":"Delta opioid receptors in brain function and diseases","volume":"140","author":"Chung","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2016.03.061_bib11","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0022-3565(25)39544-3","article-title":"Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice","volume":"267","author":"Comer","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2016.03.061_bib12","first-page":"30","article-title":"Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo","volume":"316","author":"Endoh","year":"1992","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejphar.2016.03.061_bib13","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0022-3565(24)38063-2","article-title":"Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine","volume":"288","author":"Fairbanks","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2016.03.061_bib14","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00213-014-3723-y","article-title":"Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice","volume":"232","author":"Falcon","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.061_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/76061","article-title":"Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses","volume":"25","author":"Filliol","year":"2000","journal-title":"Nat. Genet"},{"key":"10.1016\/j.ejphar.2016.03.061_bib16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1124\/jpet.111.185108","article-title":"Pharmacological characterization of 2-methyl-N-((2\u2032-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for kappa-opioid receptors","volume":"339","author":"Grimwood","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2016.03.061_bib17","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0022-3565(25)11434-1","article-title":"Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test","volume":"260","author":"Horan","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2016.03.061_bib18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/jpet.111.179432","article-title":"Preclinical pharmacology of AZD2327: a highly selective agonist of the delta-opioid receptor","volume":"338","author":"Hudzik","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2016.03.061_bib19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/383535a0","article-title":"Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin","volume":"383","author":"Konig","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2016.03.061_bib20","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1021\/jm8008986","article-title":"Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4\u2032-piperidine]-4-yl)benzamide (ADL5859)","volume":"51","author":"Le Bourdonnec","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2016.03.061_bib21","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/jcph.286","article-title":"Safety, tolerability, and pharmacokinetic evaluation of single- and multiple-ascending doses of a novel kappa opioid receptor antagonist LY2456302 and drug interaction with ethanol in healthy subjects","volume":"54","author":"Lowe","year":"2014","journal-title":"J. Clin. Pharm."},{"key":"10.1016\/j.ejphar.2016.03.061_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130100694","article-title":"Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice","volume":"155","author":"Lucki","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.061_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats","volume":"305","author":"Mague","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2016.03.061_bib24","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0166-2236(88)90093-8","article-title":"Anatomy of CNS opioid receptors","volume":"11","author":"Mansour","year":"1988","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2016.03.061_bib25","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/sj.npp.1300872","article-title":"Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system","volume":"31","author":"McLaughlin","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.061_bib26","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","article-title":"Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses","volume":"23","author":"McLaughlin","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2016.03.061_bib27","doi-asserted-by":"crossref","first-page":"8000","DOI":"10.1021\/jm200789r","article-title":"Discovery of aminobenzyloxyarylamides as kappa opioid receptor selective antagonists: application to preclinical development of a kappa opioid receptor antagonist receptor occupancy tracer","volume":"54","author":"Mitch","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2016.03.061_bib28","first-page":"132","article-title":"NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action","volume":"566","author":"Naidu","year":"2007"},{"key":"10.1016\/j.ejphar.2016.03.061_bib29","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1111\/bph.12852","article-title":"In vivo properties of KNT-127, a novel delta opioid agonist: receptor internalisation, antihyperalgesia and antidepressant effects in mice","volume":"171","author":"Nozaki","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.03.061_bib30","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neuropharm.2007.10.007","article-title":"Withdrawal from chronic administration of cocaine decreases delta opioid receptor signaling and increases anxiety- and depression-like behaviors in the rat","volume":"54","author":"Perrine","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2016.03.061_bib31","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","article-title":"Psychotomimesis mediated by kappa opiate receptors","volume":"233","author":"Pfeiffer","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2016.03.061_bib32","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1073\/pnas.98.4.1958","article-title":"Female preproenkephalin-knockout mice display altered emotional responses","volume":"98","author":"Ragnauth","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2016.03.061_bib33","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1124\/jpet.103.054668","volume":"308","author":"Rawls","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2016.03.061_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000112867","article-title":"Antidepressant-like effects of the novel kappa opioid antagonist MCL-144B in the forced-swim test","volume":"81","author":"Reindl","year":"2008","journal-title":"Pharmacology"},{"key":"10.1016\/j.ejphar.2016.03.061_bib35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuropharm.2013.09.021","article-title":"LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders","volume":"77","author":"Rorick-Kehn","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2016.03.061_bib36","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1254\/jphs.FPJ04014X","article-title":"Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents","volume":"95","author":"Saitoh","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2016.03.061_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbr.2011.04.041","article-title":"The novel delta opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions","volume":"223","author":"Saitoh","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejphar.2016.03.061_bib38","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pharmthera.2007.06.011","article-title":"Dynorphin and the pathophysiology of drug addiction","volume":"116","author":"Shippenberg","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2016.03.061_bib39","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1471-4159.2004.02589.x","article-title":"Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects","volume":"90","author":"Shirayama","year":"2004","journal-title":"J. Neurochem"},{"key":"10.1016\/j.ejphar.2016.03.061_bib40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pharmthera.2010.04.011","article-title":"The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations","volume":"127","author":"Tallarida","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2016.03.061_bib41","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.brainres.2005.11.005","article-title":"Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats","volume":"1069","author":"Torregrossa","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2016.03.061_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/jpet.110.170969","article-title":"Dual efficacy of delta opioid receptor-selective ligands for ethanol drinking and anxiety","volume":"335","author":"van Rijn","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2016.03.061_bib43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00213-013-3195-5","article-title":"Role of kappa-opioid receptors in stress and anxiety-related behavior","volume":"229","author":"Van\u2019t Veer","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2016.03.061_bib44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.peptides.2007.10.012","article-title":"Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist","volume":"29","author":"Vergura","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2016.03.061_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2007.05.045","article-title":"Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies","volume":"570","author":"Zhang","year":"2007","journal-title":"Eur. J. Pharm."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916302011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916302011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T02:56:33Z","timestamp":1748832993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916302011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":45,"alternative-id":["S0014299916302011"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.03.061","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.03.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}